Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDX19A divergent transcript (DDX19A-DT) is an annotated RNA transcript associated with the DDX19A gene locus. Its biological significance, molecular function, and disease relevance are currently unknown. DDX19A (parent gene) encodes a DEAD-box RNA helicase that is involved in mRNA nuclear export and resolution of R-loops to maintain genome integrity during DNA replication and transcription[1][2]. The divergent transcript itself is not reported to encode a protein or function as a classical therapeutic target, receptor, or biomarker. There is no evidence at present supporting its druggability, involvement in disease, or utility in patient selection[3].
None. No mechanisms of action identified for drugs targeting this transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDX19A divergent transcript (DDX19A-DT).